IL6 and COVID-19: Remarkably, one of the hallmarks of severe/critical form of COVID‐19 is the weak and delayed IFN‐I response along with an overproduction of both pro and anti‐inflammatory cytokines such as interleukin 1β (IL‐1β), 6 (IL‐6), and 10 (IL‐10), tumor necrosis factor α (TNF‐α), and transforming growth factor β (TGF‐β).10, 11, 12, 13